Insurance for unexpected expenses in case of complications during treatment and 48 months after treatment Coverage up to 200,000 USD


Dr.Didem Karaçetin (Radiation oncologist)– Best Costs, Reviews – Book Your Consultation
Prof. Dr. Didem Karaçetin is a highly experienced radiation oncologist practicing at Biruni University Hospital in Istanbul, Turkey. She has over 31 years of expertise in cancer radiotherapy and specializes in precise and advanced treatment protocols.
- Full Name: Prof. Dr. Didem Karaçetin
- Title: Professor of Radiation Oncology
- Years of Experience: 31 years
- Main Specialty: Radiation treatment for various cancers
Educational Background
Dr. Karaçetin holds strong academic credentials with international training in radiation oncology:
- MD: Trakya University Faculty of Medicine, Turkey (1982–1988)
- Radiation Oncology Residency: Şişli Etfal Training and Research Hospital, Istanbul (1994–1998)
- Clinical Training: Princess Margaret Hospital, Toronto, Canada (1996) – Radiation oncology fellowship
- Master’s Degree: Phytotherapy, Istanbul University Faculty of Pharmacy (2017–2018)
Professional Experience
- Current Position: Professor, Biruni University Hospital, Department of Radiation Oncology (2024–present)
- Previous Leadership Roles:
- Head of Radiation Oncology, Health Sciences University – Bursa, İzmir & Istanbul Hamidiye Faculties of Medicine (2021–2024)
- Educational & Administrative Director, Başakşehir Çam and Sakura City Hospital (2020–2024)
- Founder/Chief Supervisor, Radiation Oncology Centre at Dr. Sadi Konuk Training & Research Hospital (2009–2015)
- Chief Assistant, Şişli Etfal Training & Research Hospital (1998–2009)
- Teaching Role: Lecturer at Gelişim University Health Vocational School (2013–2020)
Academic Contributions
- Regular lecturer at national and international oncology conferences
- Research interest in breast, gynecological, prostate, gastrointestinal, lung, brain, head and neck cancers
- Certified in Hydrogel SpaceOAR application for prostate cancer radiotherapy
- Active role within Turkish Society for Radiation Oncology (working groups)
- Innovator in integrating AI technologies into radiotherapy planning (2023 project collaboration)
Areas of Expertise
Dr. Karaçetin provides targeted radiation therapy for a diverse range of cancers:
- Breast cancer: Standard and intraoperative radiotherapy
- Gynecological cancers: Brachytherapy applications
- Prostate cancer: SpaceOAR hydrogel placement to protect the rectum during therapy
- Gastrointestinal cancers: External and internal radiotherapy
- Lung, brain, head & neck cancers: Precise radiation planning and delivery
Publications and Research
Dr. Karaçetin has a strong record of peer-reviewed publications:
- 2009 – Karacetin D. et al. – Capecitabine and oxaliplatin (XELOX) as first-line treatment for metastatic colorectal cancer
- 2011 – Yılmaz O.B. & Karacetin D. – E-cadherin/β-catenin expression in colorectal carcinoma (Pol J Pathol)
- 2011 – Karacetin D. et al. – Temozolomide with radiotherapy vs. radiation alone in glioblastoma patients
- ResearchGate lists over 31 publications with significant clinical relevance in radiation oncology
Patient Care Philosophy
Her patient-centred approach emphasizes personalized and empathetic care:
- Commits to clear communication and detailed treatment education
- Ensures multidisciplinary support for complex cancer cases
- Supports international patients through tailored planning and coordination
- Leverages innovations like SpaceOAR and AI to minimize side effects and improve accuracy
Professional Affiliations
- Turkish Society for Radiation Oncology – working group member
- Head of Integration Group, Turkish Society for Radiation Oncology (2023)
- Member, Interdisciplinary Oncology Association
- Editor, Cam & Sakura Medical Journal (since 2021)
- Member, Turkish Medical Association
FAQs
- Is Dr. Didem Karaçetin board-certified?
- Yes. She is formally certified in radiation oncology in Turkey and has completed international fellowship training.
- What types of radiation therapy does she offer?
- She provides intraoperative radiotherapy, brachytherapy, external beam radiotherapy, and SpaceOAR‑protected prostate therapy.
- Does she treat international patients?
- Yes. Biruni University Hospital supports international cancer patients with coordinated pre-treatment planning and follow-up care.
- How long is the typical hospital stay?
- Radiotherapy is mostly outpatient, though some treatments (e.g., brachytherapy) may require 1–2 days of hospital stay.
- What languages does she speak?
- She is fluent in Turkish and English.
- Is she experienced in advanced radiotherapy techniques?
- Yes. She is certified in SpaceOAR hydrogel applications and leads integration of AI in radiotherapy planning.
- What cancers does she treat?
- Her expertise includes breast, gynecological, prostate, gastrointestinal, lung, brain, head and neck cancers.
Patient reviews
Patient reviews



